Thursday, February 29, 2024
Blue Heron Capital, an early-stage growth equity firm, is thrilled to announce its recent investment in Redi Health, an innovative digital health company poised to revolutionize patient support services. This strategic investment reflects Blue Heron's commitment to identifying and nurturing companies that not only demonstrate growth potential but also address critical needs within the healthcare and technology sectors, both of which are undergoing significant transformation.
The $14M Series B funding round, led by Blue Heron Capital, saw contributions from existing investors such as Refinery Ventures, Mutual Capital Partners, Rev1 Ventures, and M25. This substantial infusion of capital will enable Redi Health to drive innovation, develop and introduce new products, expand its patient network, and accelerate its growth trajectory. Redi Health's primary goal is to improve patient health outcomes by facilitating seamless connectivity among Pharma, Providers, and Patients, thus bridging essential gaps in patient support services.
Conventional Patient Support Programs (PSPs) have been hampered by outdated structures and limited accessibility, resulting in alarmingly high non-adherence rates of approximately 70% and substantial annual losses exceeding $600 billion for the pharmaceutical industry. Redi Health's advanced platform offers a holistic solution by providing medication reminders, symptom management tools, access to educational resources, and real-time information exchange.
Blue Heron Capital's investment underscores its dedication to fostering innovation that transcends conventional boundaries and empowers patients. The appointment of Jim Clair, a respected member of the Blue Heron OA Collaborative, to Redi Health's Board of Directors further emphasizes this commitment, reflecting confidence in Redi Health's vision and leadership team.
Source: businesswire.com
